101 related articles for article (PubMed ID: 7310197)
1. [Serum ferritin levels in patient with gynecological malignancy--especially the judgement of therapeutic response and the monitor during the post-therapeutic follow-up period (author's transl)].
Washizuka N; Yamazaki T; Shimizu T; Kikuchi Y
Nihon Sanka Fujinka Gakkai Zasshi; 1981 Oct; 33(10):1695-702. PubMed ID: 7310197
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of serum ferritin in female genital neoplasms].
Dong MY
Zhonghua Fu Chan Ke Za Zhi; 1991 Jan; 26(1):21-3, 61. PubMed ID: 1848498
[TBL] [Abstract][Full Text] [Related]
3. [Ferritin levels in patients with cervical squamous cell carcinoma (author's transl)].
Nomiyama H
Acta Obstet Gynaecol Jpn; 1981 Feb; 33(2):245-9. PubMed ID: 7234335
[TBL] [Abstract][Full Text] [Related]
4. Serum ferritin in hepatocellular carcinoma.
Zhou XD; Stahlhut MW; Hann HL; London WT
Hepatogastroenterology; 1988 Feb; 35(1):1-4. PubMed ID: 2452122
[TBL] [Abstract][Full Text] [Related]
5. [CEA and the clinical course in advanced carcinoma of the uterine cervix (author's transl)].
Braun P; Leyendecker G
Geburtshilfe Frauenheilkd; 1982 Jun; 42(6):462-7. PubMed ID: 6921128
[TBL] [Abstract][Full Text] [Related]
6. [Serum levels of a immunosuppressive acidic protein in patients with gynecological cancer (author's transl)].
Suzuki H; Miyoshi T; Sasaki H; Yoshida T
Acta Obstet Gynaecol Jpn; 1981 Apr; 33(4):513-8. PubMed ID: 6785990
[No Abstract] [Full Text] [Related]
7. [Investigation of serum immunosuppresive acidic protein levels in gynecological tumor].
Zhang W; Wang P; Zhao Y
Zhonghua Yi Xue Za Zhi; 1999 Mar; 79(3):194-6. PubMed ID: 11601039
[TBL] [Abstract][Full Text] [Related]
8. Serum alpha fetoprotein in gynaecologic related malignancies.
Ishiguro T; Yoshida Y; Tenzaki T; Ohsima M; Suzuki H
Zentralbl Gynakol; 1980; 102(21):1209-12. PubMed ID: 6163266
[TBL] [Abstract][Full Text] [Related]
9. [Serum ferritin and trophoblastic globulin in genital tumors in women].
Griaznova IM; Borisenko SA; Markarov OV; Fomina MB; Prokopenko PG; Tatarinov IuS
Vopr Onkol; 1990; 36(2):181-7. PubMed ID: 2180208
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic usefulness of stepwise discriminant analysis employing the values of CA125, TPA, IAP, CEA and ferritin in sera measured simultaneously for gynecological malignant neoplasms].
Yabushita H; Masuda T; Hattori A; Noguchi M; Ito Y; Nakanishi M; Ishihara M
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep; 37(9):1883-92. PubMed ID: 2997349
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significances of tissue polypeptide antigen in patients with gynecological malignancies].
Ueda M; Sudo N; Furuya M; Arakawa O; Ikarashi T
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2361-8. PubMed ID: 3001201
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of serum ferritin and acute phase reactant proteins levels in patients with cervical cancer].
Xie JF
Zhonghua Fu Chan Ke Za Zhi; 1991 Mar; 26(2):92-4, 124. PubMed ID: 1713541
[TBL] [Abstract][Full Text] [Related]
13. Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases.
Riisbro R; Stephens RW; Brünner N; Christensen IJ; Nielsen HJ; Heilmann L; von Tempelhoff GF
Gynecol Oncol; 2001 Sep; 82(3):523-31. PubMed ID: 11520150
[TBL] [Abstract][Full Text] [Related]
14. Measurement of ferritin-bearing peripheral mononuclear blood cells in cancer patients by radioimmunoassay.
Bluestein BI; Luderer AA; Hess D; Smith D; Meyer KK; Boyle G; Carter AC
Cancer Res; 1984 Sep; 44(9):4131-6. PubMed ID: 6744324
[TBL] [Abstract][Full Text] [Related]
15. [Gynecological cancer and ferritin--a study on the carcinofetoplacental ferritin].
Kobayashi H; Sakura H; Mizutani S
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jan; 35(1):47-52. PubMed ID: 6827163
[TBL] [Abstract][Full Text] [Related]
16. [Immunosuppressive acidic protein in patients with gynecologic cancer].
Sawada M; Matsui Y; Okudaira Y; Shimizu Y; Takayama K
Nihon Sanka Fujinka Gakkai Zasshi; 1983 May; 35(5):605-11. PubMed ID: 6408203
[TBL] [Abstract][Full Text] [Related]
17. [Pregnancy-associated alpha 2-glycoprotein in patients with gynecologic cancer].
Sawada M; Matsui Y; Okudaira Y; Shimizu Y; Takayama K
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Apr; 35(4):451-8. PubMed ID: 6854093
[TBL] [Abstract][Full Text] [Related]
18. [Assessment of serum ferritin, CEA, beta 2-MG and PAP determinations in patients with urinary tract malignancies].
Ohashi T; Tohjoh S; Takeda K; Kumon H; Morioka M; Matsumura Y; Ohmori H; Suyama B; Hironaka K
Hinyokika Kiyo; 1983 Feb; 29(2):141-53. PubMed ID: 6375313
[TBL] [Abstract][Full Text] [Related]
19. [The clinical significance of CA125 in patients with gynecological tumors--a comparative study on CA125 and other tumor markers].
Suzumori K; Yasui Y; Asai H; Hisaoka T; Mizuno K; Yagami Y
Gan No Rinsho; 1985 May; 31(5):544-8. PubMed ID: 3860666
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of different serum tumor markers in gynecological malignancies.
Paulick R; Caffier H; Horner G; Lang K; Filbry E
Cancer Detect Prev; 1985; 8(1-2):115-20. PubMed ID: 4064031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
